← All organizations

German CLL Study Group

Academic/HospitalWebsite ↗

Also known as: German CLL Study Group

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jun 11, 2025

Timeline

1990s

Jan 1, 1996
German CLL Study Group— Founded

Drugs by trial phase (40 distinct, 48 trials)

Phase 3 (14 own, 0 via acquisition)

Phase 2 (26 own, 0 via acquisition)

Indications

Studied for

Recent trials (50)

NCT06943872CollaboratorPhase 3Jun 11, 2025
NCT05791409CollaboratorPhase 1/Phase 2Nov 9, 2023
NCT05197192Lead sponsorPhase 3Apr 19, 2022
NCT04883749Lead sponsorPhase 2Jun 1, 2021
NCT04608318Lead sponsorPhase 3Dec 31, 2020
NCT04608318Overall official - principal investigatorPhase 3Dec 31, 2020
NCT04515238Lead sponsorPhase 2Oct 1, 2020
NCT04515238Overall official - principal investigatorPhase 2Oct 1, 2020
NCT04271956Lead sponsorPhase 2Mar 31, 2020
NCT03787264Overall official - principal investigatorPhase 2Jan 14, 2019
NCT03787264Lead sponsorPhase 2Jan 14, 2019
NCT03153514Lead sponsorPhase 2Jun 1, 2017
NCT02983617CollaboratorPhase 2Apr 6, 2017
NCT02968563CollaboratorPhase 2Dec 13, 2016
NCT02950051Lead sponsorPhase 3Oct 1, 2016

Details

Founded: Cologne, DE Jan 1, 1996
Last known activity: Jun 11, 2025